Browse Items (41 total)
- Tags: Drug Resistance
The treatment of herpes simplex infections: an evidence-based review.
Tags: 2-Aminopurine/analogs & derivatives/therapeutic use, 2008, Acyclovir/analogs & derivatives/therapeutic use, Antiviral Agents/*therapeutic use, Archives of internal medicine, Brodell Robert T, Cernik Christina, Department of Internal Medicine, Drug Resistance, Evidence-Based Medicine, Famciclovir, Gallina Kelly, Herpes Genitalis/*drug therapy, Herpes Labialis/*drug therapy, Humans, NEOMED College of Medicine, Recurrence, Risk Factors, Valacyclovir, Valine/analogs & derivatives/therapeutic use, Viral
Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice.
Tags: 2004, Acyclovir/administration & dosage/pharmacology/therapeutic use, Administration, Animals, Antiviral Agents/administration & dosage/pharmacology/*therapeutic use/toxicity, Antiviral research, Booth Tristan, Docherty John J, Drug Resistance, Fatty Alcohols/administration & dosage/pharmacology/therapeutic use, Fu Ming Ming, Hairless, Herpes Simplex/*drug therapy, Herpesvirus 1, Human/*drug effects/growth & development, Mice, Resveratrol, Smith Jennifer S, Stilbenes/administration & dosage/*pharmacology/*therapeutic use/toxicity, Stoner Terri, Topical, Viral
Screening and identification of novel compounds with potential anti-proliferative effects on gallium-resistant lung cancer through an AXL kinase pathway.
Tags: 2014, Alazizi Adnan, Antineoplastic Agents/chemical synthesis/chemistry/*pharmacology, Antitumor, AXL, Bioorganic & medicinal chemistry letters, Cell Line, Cell Proliferation/drug effects, Cell Survival/drug effects, Department of Pharmaceutical Sciences, Dose-Response Relationship, Drug, Drug Resistance, Drug Screening Assays, Gallium, Gallium-resistance, Gallium/pharmacology, Geldenhuys Werner J, Humans, Lin Li, Liva Sophia, Lung cancer, Lung Neoplasms/drug therapy/*enzymology/*pathology, Molecular Structure, Naphthalenes/chemistry/*pharmacology, NEOMED College of Pharmacy, Neoplasm/drug effects, Oyewumi Moses O, Proto-Oncogene Proteins/*antagonists & inhibitors/metabolism, Pyrazoles/chemistry/*pharmacology, Quinolines/chemistry/*pharmacology, Receptor Protein-Tyrosine Kinases/*antagonists & inhibitors/metabolism, Structure-Activity Relationship, Tetrazoles/chemistry/*pharmacology, Tumor, Virtual screening
Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-kappaB/HIF-1alpha pathway.
Tags: *Cancer stem cells, *Lipopolysaccharide, *Plasticity, *Stemness maintenance, *Tumor microenvironment, 2016, AC133 Antigen/genetics/*metabolism, alpha Subunit/genetics/*metabolism, Animals, Antineoplastic Agents – Pharmacodynamics, Antineoplastic Agents/pharmacology, Body Weights and Measures, Cancer letters, Carcinoma, Cell Line, Cell Movement – Drug Effects, Cell Movement/drug effects, Cell Physiology, Cell Physiology – Drug Effects, Cell Proliferation/drug effects, Department of Integrative Medical Sciences, Drug Resistance, Gene Expression Regulation, Genes, Genetic Techniques, Han Zhi-Peng, Hepatocellular, Hepatocellular – Drug Therapy, Hepatocellular – Metabolism, Hepatocellular – Pathology, Hepatocellular/drug therapy/genetics/*metabolism/pathology, Humans, Hypoxia-Inducible Factor 1, Inbred BALB C, Jing Ying-Ying, Lai Fo-Bao, Li Rong, Li Xiao-Yong, Lipopolysaccharides – Pharmacodynamics, Lipopolysaccharides/*pharmacology, Liu Jing-Feng, Liu Wen-Ting, Liver Neoplasms, Liver Neoplasms – Drug Therapy, Liver Neoplasms – Metabolism, Liver Neoplasms – Pathology, Liver Neoplasms/drug therapy/genetics/*metabolism/pathology, Male, Mice, NEOMED College of Medicine, Neoplasm, Neoplasm Invasiveness, Neoplastic, Neoplastic Stem Cells/*drug effects/metabolism/pathology, NF-kappa B – Metabolism, NF-kappa B/*metabolism, Nude, Pan Xiao-Rong, Phenotype, Proteins, Proteins – Metabolism, RNA Interference, Shi Rong-Yu, Signal Transduction – Drug Effects, Signal Transduction/drug effects, Stem Cells – Drug Effects, Stem Cells – Metabolism, Stem Cells – Pathology, Time Factors, Transfection, Tumor Burden, Tumor Microenvironment, Wei Li-Xin, Wu Meng-Chao, Yang Xue, Yu Guo-Feng, Zeng Jian-Xing, Zhang Hang-Jie, Zhang Ping, Zhao Qiu-Dong
Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
Tags: 2004, Amoxicillin-Potassium Clavulanate Combination/*therapeutic use, Anti-Bacterial Agents/pharmacology, Bacteria/drug effects/isolation & purification, Bacterial, Benninger Michael S, Clinics in laboratory medicine, Combination/*therapeutic use, Community-Acquired Infections/drug therapy/microbiology, Department of Internal Medicine, Drug Resistance, Drug Therapy, File Thomas M Jr, Humans, Jacobs Michael R, Microbial Sensitivity Tests, NEOMED College of Medicine, Pneumonia/*drug therapy/microbiology, Sinusitis/*drug therapy/microbiology
Nonresponses and treatment failures with conventional empiric regimens in patients with community-acquired pneumonia.
Antipseudomonal penicillins.
Tags: 1995, Anti-Bacterial Agents/pharmacology, Department of Internal Medicine, Drug Resistance, File T M Jr, Humans, Microbial, Microbial Sensitivity Tests, NEOMED College of Medicine, Penicillins/adverse effects/pharmacokinetics/*therapeutic use, Pseudomonas Infections/*drug therapy, Pseudomonas/*drug effects, Tan J S, The Medical clinics of North America
Community-acquired pneumonia.
Tags: *Community-Acquired Infections/diagnosis/drug therapy/microbiology, *Pneumonia, 2003, Adult, Anti-Bacterial Agents/pharmacology/therapeutic use, Bacteria/drug effects/isolation & purification, Bacterial, Bacterial/diagnosis/drug therapy/microbiology, Department of Internal Medicine, Drug Resistance, Female, File Thomas M, Humans, Lancet (London, England), Male, NEOMED College of Medicine
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanate.
Tags: *Treatment Outcome, 2002, 80 and over, Adolescent, Adult, Aged, Amoxicillin-Potassium Clavulanate Combination/administration & dosage/*pharmacokinetics/pharmacology/*therapeutic use, Amoxicillin/adverse effects/therapeutic use, Bacterial, Bacterial/drug therapy/immunology, Bronchitis/drug therapy/microbiology, Combination/adverse effects/*therapeutic use, Department of Internal Medicine, Double-Blind Method, Drug Administration Schedule, Drug Resistance, Drug Therapy, Female, File Thomas M Jr, Follow-Up Studies, Humans, International journal of antimicrobial agents, Jacobs Michael R, Male, Microbial Sensitivity Tests, Middle Aged, Multicenter Studies as Topic, NEOMED College of Medicine, Pneumonia, Poole Michael D, Respiratory Tract Infections/*drug therapy/metabolism/microbiology, Streptococcal Infections/*drug therapy/metabolism/microbiology, Streptococcus pneumoniae/*drug effects, Wynne Brian
The epidemiology of respiratory tract infections.
Tags: 2000, 80 and over, Adolescent, Adult, Age Factors, Aged, Child, Community-Acquired Infections/epidemiology, Cross Infection/epidemiology, Department of Internal Medicine, Drug Resistance, Female, File T M, Humans, Incidence, Infant, Male, Microbial, Middle Aged, NEOMED College of Medicine, Newborn, Preschool, Respiratory Tract Diseases/*epidemiology/mortality/prevention & control, Risk Factors, Seminars in respiratory infections, United States/epidemiology
On the path to untreatable infections: colistin use in agriculture and the end of 'last resort' antibiotics.
Tags: *Agriculture, *Antibiotic resistance, *Colistin, *Drug Resistance, 2016, Agriculture, Animal Husbandry, Anti-Bacterial Agents/*therapeutic use, Antibiotics – Therapeutic Use, Bacterial, Bonomo Robert A, Colistin – Analogs and Derivatives, Colistin – Therapeutic Use, Colistin/analogs & derivatives/*therapeutic use, Comparative Studies, Department of Internal Medicine, Drug Resistance, Escherichia coli, Escherichia Coli – Physiology, Escherichia coli Proteins/genetics, Escherichia coli/genetics/*physiology, European Union, Evaluation Research, Expert review of anti-infective therapy, Human, Humans, Microbial, Multicenter Studies, Multiple, NEOMED College of Medicine, Proteins, Smith Tara C, Validation Studies, Watkins Richard R
A formidable foe: carbapenem-resistant Acinetobacter baumannii and emerging nonantibiotic therapies.
Tags: *Carbapenem-resistant Acinetobacter baumannii, *decolonization, *hospital-acquired infections, *therapies, *vaccination, 2018, Acinetobacter baumannii/drug effects/*isolation & purification, Acinetobacter Infections – Microbiology, Acinetobacter Infections – Therapy, Acinetobacter Infections/microbiology/*therapy, Animals, Anti-Bacterial Agents/pharmacology, Antibiotics – Pharmacodynamics, Bacterial, Carbapenems – Pharmacodynamics, Carbapenems/pharmacology, Department of Internal Medicine, Drug Resistance, Expert review of anti-infective therapy, Gram-Negative Aerobic Bacteria, Gram-Negative Aerobic Bacteria – Drug Effects, Humans, Microbial, Microbial Culture and Sensitivity Tests, Microbial Sensitivity Tests, NEOMED College of Medicine, Watkins Richard R
SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.
Tags: *clinical trial, *Community-acquired, *Pneumonia, *solithromycin, *Streptococcus pneumoniae, 2016, 80 and over, Administration, Adult, Aged, Anti-Bacterial Agents/*administration & dosage/adverse effects, Bacterial, Bacterial/diagnosis/*drug therapy/*microbiology, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Community-Acquired Infections/diagnosis/*drug therapy/*microbiology, Comorbidity, Das Anita F, Department of Internal Medicine, Drug Resistance, Female, Fernandes Prabhavathi, File Thomas M Jr, Fluoroquinolones/*administration & dosage/adverse effects, Gonong Joven Roque V, Humans, Intravenous, Jamieson Brian D, Keedy Kara, Macrolides/*administration & dosage/adverse effects, Male, Microbial Sensitivity Tests, Middle Aged, Moxifloxacin, NEOMED College of Medicine, Oldach David, Oral, Pneumonia, Rewerska Barbara, Sheets Amanda, Taylor David, Treatment Outcome, Triazoles/*administration & dosage/adverse effects, Vucinic-Mihailovic Violeta
Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae.
Tags: 2018, benefit-risk, Bonomo Robert A, carbapenem-resistant Enterobacteriaceae, Carbapenems, Ceftazidime – Therapeutic Use, ceftazidime-avibactam, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Cober Eric, colistin, Colistin – Therapeutic Use, Comparative Studies, Department of Internal Medicine, Doi Yohei, Drug Resistance, Earley Michelle, Enterobacteriaceae Infections – Drug Therapy, Evans Scott, Fowler Vance G Jr, Human, In Vitro Studies, Kalayjian Robert C, Kaye Keith S, Klebsiella Infections, Klebsiella pneumoniae, Lok Judith J, NEOMED College of Medicine, Paterson David L, Perez Federico, Richter Sandra S, Salata Robert A, van Duin David, Watkins Richard R
New recommendations for the treatment of tuberculosis.
Tags: 2005, Adult, Antitubercular Agents – Administration and Dosage, Antitubercular Agents – Adverse Effects, Antitubercular Agents – Pharmacodynamics, Antitubercular Agents – Therapeutic Use, Antitubercular Agents/adverse effects/pharmacology/*therapeutic use, Bacterial, Chemical and Drug Induced Liver Injury, Child, Current opinion in infectious diseases, Department of Internal Medicine, Drug Resistance, Female, Hepatitis, HIV Infections – Complications, HIV Infections/complications, Humans, Infant, Microbial, Multiple, Myers Joseph P, NEOMED College of Medicine, Practice Guidelines, Practice Guidelines as Topic, Preschool, Prescribing Patterns – Standards, Tuberculin Test, Tuberculosis – Drug Therapy, Tuberculosis – Epidemiology, Tuberculosis – Prevention and Control, Tuberculosis/*drug therapy/epidemiology/prevention & control, United States
Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Tags: 1994, Acyclovir/pharmacology, Amino Acid Sequence, Antiviral Agents/metabolism/*pharmacology, Base Sequence, Binding Sites, Bromodeoxyuridine/*analogs & derivatives/metabolism/pharmacology, Deoxyuridine/analogs & derivatives/pharmacology, DNA, Docherty J J, Drug Resistance, Herpesvirus 1, Human/drug effects/*enzymology/genetics, Humans, Kinetics, Microbial, Molecular Sequence Data, Phosphonoacetic Acid/pharmacology, Phosphorylation, Point Mutation/genetics, Sequence Analysis, The Journal of general virology, Thymidine Kinase/genetics/metabolism, Thymidine/metabolism, Vidarabine/pharmacology, Wilber B A
Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia.
Tags: 2006, Anti-Infective Agents/*therapeutic use, Bacterial, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Community-Acquired Infections/*drug therapy/economics/*microbiology, Department of Internal Medicine, Drug Resistance, File T M Jr, Fluoroquinolones/*therapeutic use, Humans, Ketolides/therapeutic use, Multiple, NEOMED College of Medicine, Pneumococcal/*drug therapy/economics/*microbiology, Pneumonia, Streptococcus pneumoniae/*growth & development
Optimal treatment strategies for community-acquired pneumonia: non-responders to conventional regimens.
Tags: 2001, Anti-Infective Agents/therapeutic use, Chemotherapy, Community-Acquired Infections/drug therapy/microbiology/pathology, Department of Internal Medicine, Drug Resistance, Female, File T M Jr, Humans, Male, Microbial, NEOMED College of Medicine, Ofloxacin/therapeutic use, Pneumonia/*drug therapy/etiology/pathology, Practice Guidelines as Topic, Suppuration/drug therapy/pathology, Treatment Failure
Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Tags: 1991, Animals, Antibodies, Antiviral Agents/*pharmacology, Bromodeoxyuridine/*analogs & derivatives/pharmacology, DNA, Dobson A T, Docherty J J, Drug Resistance, Female, Fluorescent Antibody Technique, Humans, Intervirology, Jennings B A, Microbial, Monoclonal, Simplexvirus/*drug effects/enzymology/genetics, Thymidine Kinase/analysis/genetics, Trimble J J, Viral/analysis/biosynthesis, Virus Replication/drug effects
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).
Tags: *International Cooperation, *Intraabdominal Infections/diagnosis/drug therapy/microbiology, 2016, Abbott Iain J, Abu-Zidan Fikri M, Adesunkanmi Abdulrashid Kayode, Agresta Ferdinando, Al-Dahir Sara, Al-Hasan Majdi N, Althani Asma A, Ansaloni Luca, Ansari Shamshul, Ansumana Rashid, Anti-Infective Agents/*pharmacology, Augustin Goran, Bala Miklosh, Balogh Zsolt J, Baraket Oussama, Bassetti Matteo, Beltran Marcelo A, Bernhard Michael, Bhangu Aneel, Biffl Walter L, Boermeester Marja A, Brecher Stephen M, Brink Adrian J, Buyne Otmar R, Cainzos Miguel A, Cairns Kelly A, Camacho-Ortiz Adrian, Catena Fausto, Chandy Sujith J, Cherry-Bukowiec Jill R, Chichom-Mefire Alain, Coccolini Federico, Coimbra Raul, Colijn Caroline, Corcione Antonio, Corcione Francesco, Cui Yunfeng, Curcio Daniel, De Simone Belinda, De Waele Jan J, Delibegovic Samir, Demetrashvili Zaza, Department of Internal Medicine, Dhingra Sameer, Di Carlo Isidoro, Di Saverio Salomone, Diaz Jose J, Dillip Angel, Dogjani Agron, Dorj Gereltuya, Doyle Michael P, Drug Resistance, Dupont Herve, Eachempati Soumitra R, Eckmann Christian, Egiev Valery N, Elmangory Mutasim M, Enani Mushira Abdulaziz, Ferrada Paula, Fitchett Joseph R, Fraga Gustavo P, Ghnnam Wagih, Giamarellou Helen, Gkiokas George, Goldberg Staphanie R, Gomes Carlos Augusto, Gomi Harumi, Griffiths Ewen A, Guessennd Nathalie, Guzman-Blanco Manuel, Hansen Sonja, Haque Mainul, Hecker Andreas, Heizmann Wolfgang R, Herzog Torsten, Hodonou Adrien Montcho, Hong Suk-Kyung, Humans, Inaba Kenji, Isik Arda, Iskandar Katia, Ivatury Rao R, Junior Gerson Alves Pereira, Jusoh Asri Che, Kafka-Ritsch Reinhold, Kaplan Lewis J, Kapoor Garima, Karamarkovic Aleksandar, Kees Martin G, Kenig Jakub, Khokha Vladimir, Kiguba Ronald, Kim Peter K, Kirkpatrick Andrew W, Kluger Yoram, Knox Matthew C, Koike Kaoru, Kok Kenneth Y Y, Kong Victory, Kumar Anand, Labbate Maurizio, Labricciosa Francesco M, Laterre Pierre-Francois, Latifi Rifat, Lee Jae Gil, Lee Young Ran, Leone Marc, Leppaniemi Ari, Li Yousheng, Liang Stephen Y, Loho Tonny, Lowman Warren, Maegele Marc, Maier Ronald V, Malama Sydney, Marei Hany E, Martin-Loeches Ignacio, Marwah Sanjay, Massele Amos, May Addison K, Mazuski John E, McFarlane Michael, Melo Renato Bessa, Melotti Rita M, Mertz Dominik, Microbial, Microbial Sensitivity Tests, Montravers Philippe, Moore Ernest E, Moore Frederick A, Negoi Ionut, NEOMED College of Medicine, Nicolau David P, Nord Carl Erik, Ofori-Asenso Richard, Omari AbdelKarim H, Ordonez Carlos A, Ouadii Mouaqit, Piazza Diego, Prognosis, Pupelis Guntars, Rawson Timothy Miles, Rems Miran, Rizoli Sandro, Roberts Jason A, Rocha Claudio, Ruppe Etienne, Sakakushev Boris, Sanchez-Garcia Miguel, Sartelli Massimo, Sato Norio, Sawyer Rob G, Segovia Lohse Helmut A, Sganga Gabriele, Shelat Vishal G, Siribumrungwong Boonying, Soreide Kjetil, Soto Rodolfo, Spellberg Brad, Talving Peep, Tilsed Jonathan V, Timsit Jean Francois, Trueba Gabriel, Trung Ngo Tat, Uhl Waldemar, Ulrych Jan, van Goor Harry, Vereczkei Andras, Viale Perluigi, Vincent Jean-Louis, Viscoli Claudio, Vohra Ravinder S, Wani Imtiaz, Watkins Richard R, Weber Dieter G, World journal of emergency surgery : WJES, Wright Brian J, Xiao Yonghong, Yuan Kuo-Ching, Zachariah Sanoop K, Zahar Jean-Ralph, Zakrison Tanya L
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
Tags: 2004, Bacterial, Bacterial/*drug therapy, Blasi Francesco, Canada, Chest, Chidiac Christian, Community-Acquired Infections/drug therapy, Department of Internal Medicine, Drug Resistance, Europe, File Thomas M Jr, Fluoroquinolones/therapeutic use, Garau Javier, Humans, Klugman Keith, Lactams/therapeutic use, Lode Hartmut, Lonks John R, Macrolides/therapeutic use, Mandell Lionel, NEOMED College of Medicine, Pneumonia, Practice Guidelines as Topic, Ramirez Julio, United States, Yu Victor
International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.
Tags: 2003, Adjuvants, Adult, Anti-Infective Agents/*therapeutic use, Bacterial, Bacterial/*drug therapy/microbiology, Clinical Trials as Topic, Community-Acquired Infections/drug therapy/microbiology, Department of Internal Medicine, Drug Resistance, Drugs, File Thomas M Jr, Humans, Immunologic/pharmacology/therapeutic use, Inpatients, Macrolides/pharmacology/*therapeutic use, Microbial Sensitivity Tests, NEOMED College of Medicine, Outpatients, Pneumonia, Practice Guidelines as Topic, Tan James S, Treatment Failure
Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer.
Tags: 2017, ADME, Animals, Antineoplastic Agents/*therapeutic use, Apoptosis, Brain cancer, Brain Neoplasms/*drug therapy/pathology/*secondary, Breast Neoplasms/*pathology, Cell Line, Chemotherapy, CNS, Current cancer drug targets, Department of Anatomy & Neurobiology, distribution, Drug Discovery, Drug Resistance, Female, Geldenhuys Werner J, Griffith Jessica I G, Humans, Lockman Paul R, Mice, NEOMED College of Medicine, Safadi Fayez F, Sondag Gregory R, Terell-Hall Tori B, Tumor, Venishetty Vinay K
Urinary tract infections in obstetrics and gynecology.
Tags: 1990, Anti-Bacterial Agents/pharmacology/*therapeutic use, Department of Internal Medicine, Drug Resistance, Escherichia coli/drug effects, Female, File T M Jr, Humans, Lactams, Microbial, NEOMED College of Medicine, Pregnancy, Quinolones/therapeutic use, Tan J S, The Journal of reproductive medicine, Urinary Tract Infections/*drug therapy
Statin Use Is Associated With a Lower Risk of Community-acquired Staphylococcus aureus Bacteremia.
Tags: 2017, Bacteremia – Risk Factors, Biofilms – Drug Effects, Cell Physiology – Drug Effects, Community-Acquired Infections – Drug Therapy, Department of Internal Medicine, Drug Resistance, Infectious Disease Alert, Microbial, NEOMED College of Medicine, Neutrophils, Risk Assessment, Simvastatin – Administration and Dosage, Staphylococcus Aureus – Drug Effects, Statins – Economics, Statins – Therapeutic Use, Watkins Richard R
The risk of prescribing antibiotics “just-in-case” there is infection.
Tags: 2018, adverse drug event, Antibiotic Prophylaxis, Antibiotics – Adverse Effects, Department of Internal Medicine, Drug Resistance, Drugs, Goff Debra A, Inappropriate Prescribing, JrFile Thomas M, Microbial, NEOMED College of Medicine, Patient Safety, Prescribing Patterns, Prescription, Professional Knowledge, Seminars in Colon & Rectal Surgery
Optimizing Antimicrobial Utilization: Job of a Steward, or Time for a Pilot?...Bush LM, Kaye D. Optimizing antimicrobial utilization: job of a steward, or time for a pilot? Clin Infect Dis 2017; 65:1195
Tags: 2017, Antiinfective Agents – Therapeutic Use, Bauer Karri A, Bush Larry M, Centers for Disease Control and Prevention (U.S.), Clinical Infectious Diseases, Communicable Diseases – Drug Therapy, Department of Internal Medicine, Drug Resistance, Drug Utilization, File Thomas M Jr, Goff Debra A, Hospital Programs, Infection – Drug Therapy, Infectious – Drug Therapy, Kaye Donald, Kullar Ravina, Leadership, Microbial, NEOMED College of Medicine, Pharmacists, Physicians, Pilots, Skin Diseases
Cranberry Capsules Are Not Effective in Preventing Bacteriuria with Pyuria in Elderly Women in Nursing Homes.
Tags: 2016, 80 and over, Aged, Antibiotics – Therapeutic Use, Capsules – Administration and Dosage – In Old Age, Confidence Intervals, Cranberry – Therapeutic Use – In Old Age, Department of Internal Medicine, Descriptive Statistics, Double-Blind Studies, Drug Resistance, Drug Utilization, Female, Fluid Intake, Gerontologic Care, Hospitalization, Inpatients, Internal Medicine Alert, Long Term Care, Microbial, Mortality, NEOMED College of Medicine, Nursing Home Patients, Odds Ratio, Plant Extracts – Therapeutic Use – In Old Age, RANDOMIZED controlled trials, Treatment Outcomes, Urinary Tract Infections – Prevention and Control – In Old Age, Watkins Richard R, Women's Health
The Growing Threat of Pyelonephritis Caused by Antibiotic-resistant Escherichia coli.
Tags: 2016, Adult, Antibiotics – Administration and Dosage, Antiinfective Agents, Biological Phenomena, Cell Culture Techniques, Community-Acquired Infections, Department of Internal Medicine, Drug Resistance, Emergency Service, Escherichia coli, Escherichia Coli Infections, Escherichia Coli Infections – Diagnosis, Female, Fluoroquinolone, Immunocompromised Host, Infectious Disease Alert, Male, Microbial, Microbial Culture and Sensitivity Tests, NEOMED College of Medicine, Pregnancy, Pyelonephritis – Complications, Pyelonephritis – Diagnosis, Pyelonephritis – Etiology, Pyelonephritis – Risk Factors, Urinalysis, Watkins Richard R
Combination Therapy for Carbapenemase-Producing Klebsiella pneumoniae Bacteremia Reduces Mortality.
Tags: 2014, Carbapenems – Therapeutic Use, Confidence Intervals – Utilization, Department of Internal Medicine, Drug Combinations – Therapeutic Use, Drug Resistance, Enzymes – Adverse Effects, Greece, Human, Infectious Disease Alert, Inpatients, Klebsiella Infections – Drug Therapy, Medical Records – Utilization, Mortality, Multicenter Studies, NEOMED College of Medicine, Odds Ratio – Utilization, Retrospective Design – Utilization, Severity of Illness, Time Factors, Watkins Richard R
The Concept of Healthcare-Associated Pneumonia Is Not Accurate for Predicting Antibiotic Resistant Pathogens.
Tags: 2014, Communicable Diseases – Diagnosis, Cross Infection – Diagnosis, Department of Internal Medicine, Drug Resistance, Human, Infectious Disease Alert, Meta Analysis, Methicillin-Resistant Staphylococcus aureus, Microbial, Microbiology, NEOMED College of Medicine, Nursing Homes, Patient Care, Pneumonia – Etiology, Pneumonia – Physiopathology, Primary Health Care, Pseudomonas Infections – Diagnosis, Serial Publications, Staphylococcal Infections, Watkins Richard R
Increasing prevalence of carbapenem-resistant Enterobacteriaceae and strategies to avert a looming crisis.
Tags: 2013, Antibiotics – Therapeutic Use, Bonomo Robert A, Carbapenems – Therapeutic Use, Department of Internal Medicine, Drug Resistance, Early Diagnosis, Enterobacteriaceae – Drug Effects, Enterobacteriaceae – Physiology, Enterobacteriaceae Infections – Diagnosis, Enterobacteriaceae Infections – Drug Therapy, Enterobacteriaceae Infections – Microbiology, Expert review of anti-infective therapy, Microbial, NEOMED College of Medicine, Watkins Richard R
Successful Decrease in Therapy Duration for Community-Acquired Pneumonia...including commentary by Watkins RR... this article originally appeared in the December 2012 issue of Infectious Disease Alert
Tags: 2013, Antibiotics – Therapeutic Use, Clostridium Infections – Risk Factors, Community-Acquired Pneumonia – Complications, Community-Acquired Pneumonia – Drug Therapy, Department of Internal Medicine, Drug Resistance, Hospital Medicine Alert, Microbial, NEOMED College of Medicine, Patient Discharge – Evaluation, Program Development, readmission, Research, Treatment Duration, United States Centers for Medicare and Medicaid Services, Watkins Richard R
The Science of Selecting Antimicrobials for Community-Acquired Pneumonia (CAP)
Tags: 2009, Antibiotics, Antibiotics – Therapeutic Use, Antiinfective Agents, Bacterial – Drug Therapy, Combination, Community-Acquired Infections – Drug Therapy, Department of Internal Medicine, Drug Resistance, Drug Therapy, File T M, Gram-Negative Bacteria, Human, Journal of Managed Care Pharmacy, Lactam – Therapeutic Use, Legionnaires' Disease – Drug Therapy, Macrolide – Therapeutic Use, Microbial, Microbial Culture and Sensitivity Tests, NEOMED College of Medicine, Pneumonia, Practice Guidelines, Quinolone – Therapeutic Use, Streptococcus
The treatment of herpes simplex infections: an evidence-based review.
Tags: 2008, Acyclovir – Analogs and Derivatives, Acyclovir – Therapeutic Use, Antiviral Agents – Therapeutic Use, Archives of internal medicine, Brodell R T, Cernik C, Department of Internal Medicine, Drug Resistance, Evidence-Based, Gallina K, Herpes Genitalis – Drug Therapy, Herpes Simplex – Drug Therapy, Medical Practice, Microbial, NEOMED College of Medicine, Purines – Analogs and Derivatives, Purines – Therapeutic Use, Recurrence, Risk Factors, Valine, Valine – Therapeutic Use
Treating CAP caused by penicillin-resistant S pneumoniae.
Community-acquired pneumonia.
Tags: 2003, Antibiotics – Therapeutic Use, Bacterial, Bacterial – Diagnosis, Bacterial – Drug Therapy, Bacterial – Microbiology, Bacterial – Prevention and Control, Community-Acquired Infections, Community-Acquired Infections – Diagnosis, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Community-Acquired Infections – Prevention and Control, Department of Internal Medicine, Disease Progression, Drug Resistance, File T M Jr, Immunocompetence, Lancet, Microbial, NEOMED College of Medicine, Pneumonia, Severity of Illness, Streptococcus – Drug Effects, Vaccines – Therapeutic Use
Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resistance patterns.
Tags: 2004, Antibiotics, Bacteria – Drug Effects, Benninger MS, Clinics in laboratory medicine, Combined – Therapeutic Use, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Microbiology, Department of Internal Medicine, Drug Resistance, File T M Jr, Jacobs MR, Microbial, Microbial Culture and Sensitivity Tests, NEOMED College of Medicine, Pneumonia – Drug Therapy, Pneumonia – Microbiology, Rhinosinusitis – Drug Therapy, Rhinosinusitis – Microbiology
Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
Tags: 2004, Antibiotics, Antibiotics – Administration and Dosage, Antiinfective Agents, Bacterial – Drug Therapy, Blasi F, Canada, Chest, Chidiac C, Community-Acquired Infections – Drug Therapy, Comparative Studies, Department of Internal Medicine, Drug Resistance, Europe, File T M Jr, Fluoroquinolone – Therapeutic Use, Garau J, Klugman K, Lactam – Therapeutic Use, Lode H, Lonks JR, Macrolide – Therapeutic Use, Mandell L, Microbial, NEOMED College of Medicine, Pneumonia, Practice Guidelines, Ramirez J, United States, Yu V
International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.
Tags: 2003, Antibiotics, Clinical Trials, Community-Acquired Infections – Drug Therapy, Community-Acquired Infections – Etiology, Department of Internal Medicine, Drug Resistance, Drugs, File T M Jr, Immune System – Drug Effects, Inpatients, Macrolide – Pharmacodynamics, Macrolide – Therapeutic Use, Methicillin Resistance, Microbial, NEOMED College of Medicine, Nonexperimental Studies, Outpatients, Pneumonia – Drug Therapy, Pneumonia – Etiology, Practice Guidelines, Risk Assessment, Streptococcal Infections – Drug Therapy, Tan J S